CP
Clearwater Paper Corp (CLW)·Q2 2025 Earnings Summary
Executive Summary
- Q2 delivered net sales of $391.8M, diluted EPS from continuing operations of $0.22, and Adjusted EBITDA of $39.9M, reflecting higher volume from the Augusta mill, lower fixed costs, and successful completion of the Cypress Bend outage .
- Versus S&P Global consensus, revenue modestly missed ($391.8M vs $397.0M*) and EPS significantly missed ($0.22 vs $0.70*), while Adjusted EBITDA was essentially in line ($39.9M vs $40.1M*) .
- Management guided Q3 Adjusted EBITDA to $10–$20M with flat shipments vs Q2, a $23–$25M Lewiston outage, ~5% lower production and minimal tariff impacts; FY25 assumptions maintained (revenue $1.5–$1.6B, capex $80–$90M, direct major maintenance $45–$50M, and $30–$40M cost reductions) .
- Strategic focus remains on navigating oversupply through cost reductions and operational execution; medium-term catalysts include potential trade/tariff actions and product-line expansion (CUK/CRB, compostable/lightweight) to improve utilization and margins through the cycle .
Consensus values marked with * are retrieved from S&P Global.
What Went Well and What Went Wrong
-
What Went Well
- Cost actions tracking to plan: “on track to deliver a $30–$40M reduction this year… SG&A down nearly 14% vs last year to 6.7% of net sales,” and Adjusted EBITDA margin expanded to ~10% .
- Volume and operations: Q2 sales volumes rose 12% YoY to 304,713 tons; production rose to 323,489 tons; Augusta integration benefits continued; Cypress Bend major maintenance completed in-line with ~$9M plan .
- Capital allocation: $4M buybacks in Q2 and $18M since the authorization launch, with net leverage at ~1.9x, maintaining balance sheet flexibility .
-
What Went Wrong
- Pricing headwinds persisted: average net selling price per ton down ~3% YoY to $1,182, consistent with broader market trends and oversupply .
- Modest revenue and EPS miss vs consensus amid industry oversupply and pricing pressure; revenue $391.8M vs $397.0M*, EPS $0.22 vs $0.70* .
- Industry utilization weakened to ~83% with new capacity ramping; management expects below-normal rates near term, contributing to continued margin pressure .
Consensus values marked with * are retrieved from S&P Global.
Financial Results
Quarter-on-Quarter and Year-on-Year
Actual vs S&P Global Consensus – Q2 2025
Consensus values marked with * are retrieved from S&P Global.
End-Market/Category Mix (Net Sales $M)
Selected KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We delivered a strong second quarter that was in line with our expectations… $40 million of Adjusted EBITDA… net sales were $392 million, up 14% versus prior year, primarily driven by the Augusta acquisition” .
- “Industry utilization rates fell to 83.1% in the second quarter… likely reflects the startup of new capacity… we expect SBS industry utilization rates to remain well below historical norms in the coming quarters” .
- “We’re nearing completion of market and engineering studies on the potential entry into CUK… investment would be in the $50 million range and take around 18 months” .
- “SG&A expenses were down nearly 14% versus last year to 6.7% of net sales… driven by our cost reduction initiatives and the completion of the Augusta integration” .
Q&A Highlights
- Demand signals are mixed: shipments up ~5% sequentially at CLW with stable backlogs, while industry shipments were down; mgmt views softness as cyclical, not secular .
- Q3 bridge: ~$15M sequential increase in outage expense (Lewiston $23–$25M vs Cypress Bend ~$9M in Q2), ~5% lower production (absorption), and modest tariff impact underpin $10–$20M Adjusted EBITDA guide .
- Price trajectory: Q1–Q2 price stable; management avoids commenting on forward pricing; new capacity remains a watch item .
- Shipments/utilization cadence: Flat from Q2 to Q3, potential seasonality in Q4; utilization pressured by major outages in 2H .
Estimates Context
- Q2 2025 vs S&P Global consensus: revenue $391.8M vs $397.0M* (miss), EPS $0.22 vs $0.70* (miss), Adjusted EBITDA $39.9M vs $40.1M* (in line) .
- Forward consensus and guidance: Q3 2025 EBITDA consensus ~$15.6M* sits within the company’s $10–$20M guide; mgmt’s explicit outage costs and absorption impacts suggest Street models should reflect lower production and higher maintenance in Q3, with recovery potential post-outage .
- Target price consensus ~$30* on 2 estimates; estimate depth remains thin, increasing model dispersion risk.
Consensus values marked with * are retrieved from S&P Global.
Key Takeaways for Investors
- Volume tailwinds are intact (Augusta, food service) but price remains the core headwind; mix/pricing inflection likely requires utilization improvement (tariffs/imports, capacity rationalization) .
- Execution on cost reductions is visible (SG&A ratio, EBITDA margin improvement), providing partial offset to pricing pressure through the downcycle .
- 2H25 is outage-heavy (Lewiston Q3; Augusta Q4), depressing production and absorption; Q3 guide embeds these headwinds explicitly—post-outage normalization is a near-term setup .
- Strategic adjacency moves (CUK swing capability, CRB via M&A) could broaden addressable market without expanding overall capacity, improving asset flexibility and utilization through cycles .
- Balance sheet remains a support (net leverage ~1.9x; selective buybacks), but management does not intend to lever for repurchases—cash preservation prioritized during outages .
- Estimate revisions: Expect modest downward EPS revisions given Q2 miss and Q3 outage drag; FY framework maintained (revenue $1.5–$1.6B; capex/maintenance unchanged), anchoring medium-term modeling .
- Stock catalysts: tariff/import developments, signs of utilization improvement, progress on CUK/CRB decision by YE, and margin expansion from cost actions and pricing stabilization .
Appendix: Sources Read in Full
- Q2 2025 8-K 2.02 and Exhibit 99.1/99.2 (press release and supplemental) –.
- Q2 2025 earnings call transcript –; corroborating alternate transcript –.
- Other relevant Q2 press releases (timing/availability) .
- Prior quarters for trend analysis: Q1 2025 8-K and exhibits –; Q4 2024 8-K and exhibits – –.
Consensus values marked with * are retrieved from S&P Global.